Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H29N3O4.ClH |
Molecular Weight | 471.976 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O[C@@H](CNC1=CC=C(CCNC[C@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1)C3=CC=CC=C3
InChI
InChIKey=QQPHRRSYJMOQOC-DKIIUIKKSA-N
InChI=1S/C25H29N3O4.ClH/c29-17-28-22-14-20(8-11-23(22)30)24(31)15-26-13-12-18-6-9-21(10-7-18)27-16-25(32)19-4-2-1-3-5-19;/h1-11,14,17,24-27,30-32H,12-13,15-16H2,(H,28,29);1H/t24-,25-;/m0./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C25H29N3O4 |
Molecular Weight | 435.5155 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Milveterol (also known as GSK159797) was developed as a longer-acting beta2 adrenoceptor agonist for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Milveterol completed phase II clinical trials for asthmatic subjects. However further development of the drug was discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00358488
GSK159797 (10, 15, and 20mcg) following dosing for 14 days
Route of Administration:
Respiratory
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:41:13 GMT 2023
by
admin
on
Fri Dec 15 15:41:13 GMT 2023
|
Record UNII |
1D1MD355SJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1940832
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
PRIMARY | |||
|
1D1MD355SJ
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
PRIMARY | |||
|
C77936
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
PRIMARY | |||
|
DTXSID50230335
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
PRIMARY | |||
|
804518-03-4
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
PRIMARY | |||
|
11225217
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
PRIMARY | |||
|
SS-26
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
PRIMARY | |||
|
300000044610
Created by
admin on Fri Dec 15 15:41:13 GMT 2023 , Edited by admin on Fri Dec 15 15:41:13 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |